Clinical Trials Insight: 700028965

Trial Profile

Clinical Trials Insight: 700028965

Planning
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2007

At a glance

  • Drugs Influenza A vaccine H5N1-Baxter (Primary)
  • Indications Influenza A virus H5N1 subtype
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Baxter International; DynPort Vaccine Company
  • Most Recent Events

    • 30 Nov 2007 New trial record.
    • 27 Nov 2007 Patient enrolment is expected to begin in 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top